Trinity Biotech (TRIB) Operating Income (2016 - 2024)
Historic Operating Income for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$11.5 million.
- Trinity Biotech's Operating Income fell 20465.73% to -$11.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$21.2 million, marking a year-over-year increase of 2175.97%. This contributed to the annual value of -$21.2 million for FY2024, which is 2174.15% up from last year.
- Per Trinity Biotech's latest filing, its Operating Income stood at -$11.5 million for Q4 2024, which was down 20465.73% from -$2.6 million recorded in Q3 2024.
- Trinity Biotech's Operating Income's 5-year high stood at $9.1 million during Q3 2020, with a 5-year trough of -$14.9 million in Q2 2023.
- For the 5-year period, Trinity Biotech's Operating Income averaged around -$2.0 million, with its median value being -$2.2 million (2022).
- As far as peak fluctuations go, Trinity Biotech's Operating Income soared by 58154.54% in 2020, and later tumbled by 154884.55% in 2022.
- Quarter analysis of 5 years shows Trinity Biotech's Operating Income stood at $9.1 million in 2020, then tumbled by 93.79% to $563000.0 in 2021, then tumbled by 1548.85% to -$8.2 million in 2022, then surged by 53.67% to -$3.8 million in 2023, then tumbled by 204.66% to -$11.5 million in 2024.
- Its Operating Income was -$11.5 million in Q4 2024, compared to -$2.6 million in Q3 2024 and -$4.1 million in Q2 2024.